Literature DB >> 26041298

Distinct Immune Responses in Resistant and Susceptible Strains of Mice during Neurovirulent Alphavirus Encephalomyelitis.

Kirsten A Kulcsar1, Victoria K Baxter1, Rachy Abraham2, Ashley Nelson2, Diane E Griffin3.   

Abstract

UNLABELLED: Susceptibility to alphavirus encephalomyelitis is dependent on a variety of factors, including the genetic background of the host. Neuroadapted Sindbis virus (NSV) causes uniformly fatal disease in adult C57BL/6 (B6) mice, but adult BALB/c (Bc) mice recover from infection. In B6 mice, fatal encephalomyelitis is immune mediated rather than a direct result of virus infection. To identify the immunological determinants of host susceptibility to fatal NSV-induced encephalomyelitis, we compared virus titers and immune responses in adult B6 and Bc mice infected intranasally with NSV. B6 mice had higher levels of virus replication, higher levels of type I interferon (IFN), and slower virus clearance than did Bc mice. B6 mice had more neuronal apoptosis, more severe neurologic disease, and higher mortality than Bc mice. B6 mice had more infiltration of inflammatory cells and higher levels of IL1b, IL-6, TNFa, Csf2, and CCL2 mRNAs and interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), IFN-γ, and C-C motif ligand 2 (CCL2) protein in brains than Bc mice. However, Bc mice had more brain antibody at day 7 and a higher percentage of CD4(+) T cells. CD4(+) T cells in the brains of Bc mice included fewer Th17 cells and more regulatory T cells (Tregs) producing IL-10 than B6 mice, accompanied by higher levels of Il2 and Cxcl10 mRNAs. In the absence of IL-10, resistant Bc mice became susceptible to fatal encephalomyelitis after NSV infection. These studies demonstrate the importance of the immune response and its regulation in determining host survival during alphavirus encephalomyelitis. IMPORTANCE: Mosquito-borne alphavirus infections are an important cause of encephalomyelitis in humans. The severity of disease is dependent both on the strain of the virus and on the age and genetic background of the host. A neurovirulent strain of Sindbis virus causes immune-mediated fatal encephalomyelitis in adult C57BL/6 mice but not in BALB/c mice. To determine the host-dependent immunological mechanisms underlying the differences in susceptibility between these two strains of mice, we compared their immune responses to infection. Resistance to fatal disease in BALB/c mice was associated with better antibody responses, more-rapid virus clearance, fewer Th17 cells, and more-potent regulatory T cell responses than occurred in susceptible C57BL/6 mice. In the absence of interleukin-10, a component of the regulatory immune response, resistant mice became susceptible to lethal disease. This study demonstrates the importance of the immune response and its regulation for host survival during alphavirus encephalomyelitis.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26041298      PMCID: PMC4524229          DOI: 10.1128/JVI.00173-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Sindbis virus-induced neuronal death is both necrotic and apoptotic and is ameliorated by N-methyl-D-aspartate receptor antagonists.

Authors:  J L Nargi-Aizenman; D E Griffin
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Gamma interferon-dependent, noncytolytic clearance of sindbis virus infection from neurons in vitro.

Authors:  Rebeca Burdeinick-Kerr; Diane E Griffin
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse.

Authors:  P C Charles; J Trgovcich; N L Davis; R E Johnston
Journal:  Virology       Date:  2001-06-05       Impact factor: 3.616

4.  Extensive immune-mediated hippocampal damage in mice surviving infection with neuroadapted Sindbis virus.

Authors:  Takashi Kimura; Diane E Griffin
Journal:  Virology       Date:  2003-06-20       Impact factor: 3.616

5.  Interleukin-10 attenuates production of HSV-induced inflammatory mediators by human microglia.

Authors:  Cristina P Marques; Shuxian Hu; Wen Sheng; Maxim C-J Cheeran; Diana Cox; James R Lokensgard
Journal:  Glia       Date:  2004-09       Impact factor: 7.452

Review 6.  Zoonotic encephalitides caused by arboviruses: transmission and epidemiology of alphaviruses and flaviviruses.

Authors:  Yun Young Go; Udeni B R Balasuriya; Chong-Kyo Lee
Journal:  Clin Exp Vaccine Res       Date:  2013-12-18

7.  The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis.

Authors:  M T Lin; D R Hinton; B Parra; S A Stohlman; R C van der Veen
Journal:  Virology       Date:  1998-06-05       Impact factor: 3.616

Review 8.  Role of regulatory T cells during virus infection.

Authors:  Tamara Veiga-Parga; Sharvan Sehrawat; Barry T Rouse
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

Review 9.  Pathogenesis of acute and chronic central nervous system infection with variants of mouse hepatitis virus, strain JHM.

Authors:  Steven P Templeton; Stanley Perlman
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

10.  Role of regulatory T cells in coronavirus-induced acute encephalitis.

Authors:  Daniela Anghelina; Jingxian Zhao; Kathryn Trandem; Stanley Perlman
Journal:  Virology       Date:  2009-01-11       Impact factor: 3.616

View more
  15 in total

1.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

2.  Interleukin-10 Modulation of Virus Clearance and Disease in Mice with Alphaviral Encephalomyelitis.

Authors:  Nina M Martin; Diane E Griffin
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

3.  Interferon gamma modulation of disease manifestation and the local antibody response to alphavirus encephalomyelitis.

Authors:  Victoria K Baxter; Diane E Griffin
Journal:  J Gen Virol       Date:  2016-09-22       Impact factor: 3.891

4.  Death and gastrointestinal bleeding complicate encephalomyelitis in mice with delayed appearance of CNS IgM after intranasal alphavirus infection.

Authors:  Victoria K Baxter; Elizabeth M Troisi; Nathan M Pate; Julia N Zhao; Diane E Griffin
Journal:  J Gen Virol       Date:  2018-03       Impact factor: 3.891

Review 5.  Alphavirus Encephalomyelitis: Mechanisms and Approaches to Prevention of Neuronal Damage.

Authors:  Diane E Griffin
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

6.  The NF-κB/leukemia inhibitory factor/STAT3 signaling pathway in antibody-mediated suppression of Sindbis virus replication in neurons.

Authors:  Jane X Yeh; Kimberly L W Schultz; Valerie Calvert; Emanuel F Petricoin; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-03       Impact factor: 11.205

7.  T cell-derived interleukin-10 is an important regulator of the Th17 response during lethal alphavirus encephalomyelitis.

Authors:  Kirsten A Kulcsar; Diane E Griffin
Journal:  J Neuroimmunol       Date:  2016-04-13       Impact factor: 3.478

Review 8.  Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents.

Authors:  Ian A Clark; Bryce Vissel
Journal:  J Neuroinflammation       Date:  2016-09-05       Impact factor: 8.322

9.  Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion.

Authors:  Melody M H Li; Leonia Bozzacco; Hans-Heinrich Hoffmann; Gaëlle Breton; Jakob Loschko; Jing W Xiao; Sébastien Monette; Charles M Rice; Margaret R MacDonald
Journal:  J Exp Med       Date:  2016-11-29       Impact factor: 14.307

10.  Glutamine antagonist-mediated immune suppression decreases pathology but delays virus clearance in mice during nonfatal alphavirus encephalomyelitis.

Authors:  Victoria K Baxter; Rebecca Glowinski; Alicia M Braxton; Michelle C Potter; Barbara S Slusher; Diane E Griffin
Journal:  Virology       Date:  2017-05-19       Impact factor: 3.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.